Campari Group S.p.A. (BIT: CPR) reports H1-2026 organic net sales growth of more than 2.0% year-on-year (expected approx. July 31, 2026)
Pending
✦ AI-generated prediction
Published on 21. July 2026
·
Predicted for 31. July 2026
·
Based on: Historical Cycle
Campari Group (Aperol, Campari, Wild Turkey, Espolòn) recorded approx. –4% organic in H1 2025 but turned positive in H2 2025. Aperol price increases of ~+5% in Europe (since January 2026), recovery in the US tequila segment (Espolòn), and first-time consolidation of the Bailey acquisition support H1-2026 growth. Sector comparison: AB InBev organic +4%, Pernod Ricard guidance –3% to –4%. Campari is positioned for moderate mid-tier recovery. No prediction market quote; own calibration 55%.
Data basis for this prediction
- Campari Group FY2025: H2 2025 organisches Wachstum positiv (Campari IR, Feb. 2026)
- Aperol Preiserhöhung Europa +5 % seit Januar 2026 (Reuters, Jan. 2026)
- AB InBev H1-2026 Konsens: organisch +4 % YoY (Bloomberg Consensus, Juli 2026)
- CPR H1-Meldetermin: ca. 31. Juli 2026 (Campari Group Investor Relations Kalender)
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
🍾 Beverages
✦ AI
AB InBev reported +5.8% organic revenue growth in Q1 2026 (volume recovery), beating estimates and reiterating full-year guidance of +4–8% organic EBITDA. Q2 is historically the strongest quarter for beer (global summer peak). EPS consensus ~$1.10–1.12. No direct prediction market; own estimate: 70% for >3% organic growth.
🍾 Beverages
✦ AI
Brown-Forman (Jack Daniel's, Woodford Reserve, Herradura) guided organic net revenue of –7% to –9% for FY2026 — hit by weaker US and European demand and global spirits softness (Diageo –1 to –4%, Pernod Ricard –3 to –4% guidance). Q1 FY2027 (May–July 2026) may show early turnaround signs: US consumer sentiment improving after US-China tariff relief, premium bourbon remains structurally popular. However, reaching better than –5% requires a meaningful recovery from the FY2026 trend. No Polymarket anchor; calibrated from sector data and industry peer comparison.
🍾 Beverages
✦ AI
Molson Coors (Coors, Miller, Blue Moon, Staropramen, Madri) reports Q2 2026 before market open on August 6. Analyst consensus: $1.52 EPS — steep decline from $2.05 in prior year (-25.9% YoY). No Polymarket market found. YoY decline drivers: Hormuz-driven logistics/input costs (aluminum, barley), weaker beer volumes in Europe (UK, Belgium). Yet: Molson Coors beat EPS estimates in 3 of the last 4 quarters (~75% beat rate). Premium segment pricing power (Blue Moon, Madri, Staropramen) and ongoing cost programs should slightly outrun the conservatively set consensus. The low $1.52 benchmark makes a beat likely even if absolute levels remain weak.